26 August 2016

Ellex awarded $2.5m Federal Government Grant

Ellex Medical Lasers Limited (ASX:ELX), a global leader in medical devices for the diagnosis and treatment of eye disease, today announced it has been awarded a grant of $2.5 million from the Federal Government’s “Next Generation Manufacturing Investment Programme”. The grant award was announced by the Minister for Industry, Innovation & Science, the Hon. Greg Hunt MP.

“We are very pleased to be awarded this grant. It will facilitate the investment in advanced equipment and systems we need to expand our manufacturing capacity to satisfy the rapidly growing international demand in our ophthalmic lasers and ultrasound.” commented Ellex CEO Tom Spurling.
The award of this grant corresponds with Ellex’s manufacturing site relocation from the Adelaide CBD to Mawson Lakes, 15km north, and corresponding production capacity expansion. The grant is payable by the Government to Ellex over a period of up to 3 years.


Ellex designs, develops, manufactures and sells innovative products that help eye surgeons around the world to effectively and efficiently treat eye disease. Ellex is a world leader in this field. Headquartered in Adelaide, Australia, Ellex has ophthalmic lasers and devices that treat glaucoma, retinal disease primarily caused by diabetes, secondary cataract and vitreous opacities, as well as age-related macular degeneration. Manufacturing is carried out in Adelaide, Australia and Fremont, California. Sales and service directly to eye surgeons is conducted via subsidiary offices in Minneapolis, Lyon, Berlin and Tokyo. A network of more than 50 distribution partners around the world services other markets.

For additional information about Ellex and its products, please visit www.ellex.com

For further information on Ellex please contact:

Tom Spurling, CEO
Ellex Medical Lasers Limited
82 Gilbert Street, Adelaide, SA, 5000
W +61 8 8104 5293 | M +61 417 818 658

Maria Maieli, CFO & Company Secretary
Ellex Medical Lasers Limited
82 Gilbert Street, Adelaide, SA, 5000
W +61 8 8104 5200

Andrew Angus
Investor Relations
M +61 402 823 757